Assessment of Hematological Toxicity of Adjuvant Chemotherapy in the Complex Therapy of Breast Cancer

Volume 25, Issue 12, December 2024, Pages 4123-4128

Valentina B Sirota; Sabina Sakenovna Zhumakayeva; Nailya Amirbekovna Kabildina; Daria Dmitrievna Dorogan; Zarina Bilyalova; Sergazy M Adekenov

• View Article
• PDF 294.61 K

Evaluating the Outcome and Patient Safety of Methotrexate, Doxorubicin, and Cisplatin Regimen for Chemotherapy in Osteosarcoma: A Meta-Analysis

Volume 25, Issue 5, May 2024, Pages 1497-1505

Mohamad Dimas Ismail; I Gede Eka Wiratnaya; Risang Haryo Raditya

• View Article
• PDF 1.13 M

Neoadjuvant versus Adjuvant Chemotherapy in Patients with Resectable Muscle-Invasive Bladder Cancer

Volume 23, Issue 11, November 2022, Pages 3641-3647

Anupong Sawasdee; Monthira Tanthanuch; Tanan Bejrananda

• View Article
• PDF 549.03 K

Salvage Treatment and Outcomes of Locally Advanced Cervical Cancer after Failed Concurrent Chemoradiation with or without Adjuvant Chemotherapy: Post Hoc Data Analysis from the ACTLACC Trial

Volume 23, Issue 7, July 2022, Pages 2263-2269

Tussawan Asakij; Jakkapan Khunnarong; Siriwan Tangjitgamol; Kanisa Rongsriyam; Ekkasit Tharavichitkul; Chokaew Tovanabutra; Kannika Paengchit; Jirasak Sukhaboon; Lieutenant Col. Apiradee Kridakara; Thiti Atjimakul; Piyawan Pariyawateekul; Prapai Tanprasert

• View Article
• PDF 301.66 K

Long-Term Outcomes and Sites of Failure in Locally Advanced, Cervical Cancer Patients Treated by Concurrent Chemoradiation with or without Adjuvant Chemotherapy: ACTLACC Trial

Volume 22, Issue 9, September 2021, Pages 2977-2985

Chokaew Tovanabutra; Tussawan Asakij; Kanisa Rongsriyam; Siriwan Tangjitgamol; Ekkasit Tharavichitkul; Jirasak Sukhaboon; Lieutenant Col. Apiradee Kridakara; Kannika Paengchit; Jakkapan Khunnarong; Thiti Atjimakul; Piyawan Pariyawateekul; Prapai Tanprasert; Tharathorn Tungkasamit; Vicharn Lorvidhaya

• View Article
• PDF 399.28 K

Progress and Challenges in Chemotherapy for Loco-Regionally Advanced Nasopharyngeal Carcinoma

Volume 16, Issue 12, December 2015, Pages 4825-4832

• View Article
• PDF 616.97 K

Novel Directions in Adjuvant Chemotherapy for Early Stage Epithelial Ovarian Cancer

Volume 16, Issue 10, October 2015, Pages 4157-4160

• View Article
• PDF 340.81 K

Prognostic Factors and the Role of Adjuvant Chemotherapy in Post-curative Surgery for Dukes B and C Colon Cancers and Survival Outcomes: a Malaysian Experience

Volume 16, Issue 6, June 2015, Pages 2237-2243

• View Article
• PDF 462.55 K

Efficacy of Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel versus Conventional Dose Doxorubicin, Cyclophosphamide Followed by Paclitaxel or Docetaxel in Patients with Node-Positive Breast Cancer

Volume 16, Issue 4, April 2015, Pages 1471-1477

• View Article
• PDF 699.72 K

Carcinoma Microsatellite Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Stage II Rectal Cancer

Volume 16, Issue 4, April 2015, Pages 1545-1551

• View Article
• PDF 1.02 M

Patients with HER2-positive Early Breast Cancer Receiving Adjuvant Trastuzumab: Clinicopathological Features, Efficacy, and Factors Affecting Survival

Volume 16, Issue 4, April 2015, Pages 1643-1649

• View Article
• PDF 518.61 K

Taxane-Based Regimens as Adjuvant Treatment for Breast Cancer: a Retrospective Study in Egyptian Cancer Patients

Volume 16, Issue 1, January 2015, Pages 65-69

• View Article
• PDF 421.48 K

Prognostic Factors and Adjuvant Treatments for Surgically Treated Cancers of the Biliary Tract: A Multicentre Study of the Anatolian Society of Medical Oncology (ASMO)

Volume 15, Issue 22, December 2014, Pages 9687-9692

• View Article
• PDF 567.22 K

Genetic Variations in the HIF1A Gene Modulate Response to Adjuvant Chemotherapy after Surgery in Patients with Colorectal Cancer

Volume 15, Issue 11, November 2014, Pages 4637-4642

• View Article
• PDF 444.13 K

Prognostic Factors for Lymph Node Negative Stage I and IIA Non-small Cell Lung Cancer: Multicenter Experiences

Volume 14, Issue 11, November 2013, Pages 6287-6292

• View Article
• PDF 586.49 K

Efficacy and Tolerability of Adjuvant Oral Capecitabine plus Intravenous Oxaliplatin (XELOX) in Asian Patients with Colorectal Cancer: 4-Year Analysis

Volume 14, Issue 11, November 2013, Pages 6585-6590

• View Article
• PDF 568.69 K

Feasibility Study of Docetaxel and Cyclophosphamide Six-Cycle Therapy as Adjuvant Chemotherapy for Japanese Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients

Volume 14, Issue 8, August 2013, Pages 4835-4838

• View Article
• PDF 506.37 K

Impact of Adjuvant Chemotherapy Cycles on Prognosis of Resectable Stomach Cancer: A Retrospective Analysis

Volume 14, Issue 1, January 2013, Pages 381-386

• View Article
• PDF 427.4 K

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy with or without Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: Meta-analysis of 1,096Patients from 11 Randomized Controlle

Volume 14, Issue 1, January 2013, Pages 515-521

• View Article
• PDF 1.01 M

Evaluation of Postoperative Adjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma Patients undergoing R1 and R2 Resections

Volume 13, KKSuppl, December 2012, Pages 169-174

• View Article
• PDF 700.25 K

Comparison of Concurrent ChemoradiotherapyFollowed by Adjuvant Chemotherapy Versus ConcurrentChemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis of 793 Patients from 5 Randomized Controlled Trials

Volume 13, Issue 11, November 2012, Pages 5747-5752

• View Article
• PDF 1005.75 K

Prediction Value of XRCC 1 Gene Polymorphism on the Survival of Ovarian Cancer Treated by Adjuvant Chemotherapy

Volume 13, Issue 10, October 2012, Pages 5007-5010

• View Article
• PDF 516.21 K

Chinese Patients with Gastric Cancer Need Targeted Adjuvant Chemotherapy Schemes

Volume 13, Issue 10, October 2012, Pages 5263-5272

• View Article
• PDF 1.53 M

Risk of Treatment Related Death and Febrile Neutropaenia with Taxane-Based Adjuvant Chemotherapy for Breast Cancer in a Middle Income Country Outside a Clinical Trial Setting

Volume 13, Issue 9, September 2012, Pages 4623-4626

• View Article
• PDF 349.79 K

Evaluation of the Efficacy of Modified De Gramont and Modified FOLFOX4 Regimens for Adjuvant Therapy of Locally Advanced Rectal Cancer

Volume 12, Issue 12, December 2011, Pages 3181-3186

• View Article
• PDF 483.95 K